Sonen Capital LLC lowered its stake in Henry Schein, Inc. (NASDAQ:HSIC – Get Rating) by 3.3% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,119 shares of the company’s stock after selling 1,043 shares during the quarter. Henry Schein accounts for approximately 3.2% of Sonen Capital LLC’s portfolio, making the stock its 4th largest position. Sonen Capital LLC’s holdings in Henry Schein were worth $2,626,000 as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. AIA Group Ltd grew its holdings in Henry Schein by 32.9% in the first quarter. AIA Group Ltd now owns 2,304 shares of the company’s stock worth $201,000 after purchasing an additional 571 shares during the period. Victory Capital Management Inc. grew its holdings in Henry Schein by 15.0% in the fourth quarter. Victory Capital Management Inc. now owns 69,916 shares of the company’s stock worth $5,421,000 after purchasing an additional 9,123 shares during the period. DekaBank Deutsche Girozentrale lifted its stake in shares of Henry Schein by 2.1% in the fourth quarter. DekaBank Deutsche Girozentrale now owns 401,956 shares of the company’s stock valued at $31,326,000 after buying an additional 8,386 shares in the last quarter. Banque Pictet & Cie SA bought a new position in shares of Henry Schein in the fourth quarter valued at $2,097,000. Finally, TCW Group Inc. lifted its stake in shares of Henry Schein by 9.6% in the first quarter. TCW Group Inc. now owns 17,262 shares of the company’s stock valued at $1,505,000 after buying an additional 1,514 shares in the last quarter. Institutional investors and hedge funds own 94.30% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research analysts have weighed in on HSIC shares. Credit Suisse Group dropped their price objective on shares of Henry Schein from $100.00 to $90.00 and set an “outperform” rating on the stock in a research note on Wednesday. Piper Sandler dropped their price objective on shares of Henry Schein from $100.00 to $96.00 in a research note on Tuesday. Robert W. Baird lowered shares of Henry Schein from an “outperform” rating to a “neutral” rating and dropped their price objective for the company from $103.00 to $88.00 in a research note on Tuesday, June 14th. Barrington Research dropped their price objective on shares of Henry Schein from $102.00 to $99.00 and set an “outperform” rating on the stock in a research note on Wednesday. Finally, William Blair reissued a “market perform” rating on shares of Henry Schein in a research report on Tuesday, May 3rd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, Henry Schein has an average rating of “Hold” and an average price target of $87.14.
Henry Schein Stock Up 1.7 %
Henry Schein (NASDAQ:HSIC – Get Rating) last announced its quarterly earnings data on Tuesday, August 2nd. The company reported $1.16 EPS for the quarter, hitting the consensus estimate of $1.16. The business had revenue of $3.03 billion for the quarter, compared to analyst estimates of $3.12 billion. Henry Schein had a net margin of 5.11% and a return on equity of 15.56%. The company’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.11 earnings per share. On average, equities analysts forecast that Henry Schein, Inc. will post 4.85 EPS for the current year.
Insiders Place Their Bets
In other Henry Schein news, EVP Gerald A. Benjamin sold 11,489 shares of Henry Schein stock in a transaction dated Thursday, May 26th. The shares were sold at an average price of $85.47, for a total value of $981,964.83. Following the sale, the executive vice president now owns 95,616 shares of the company’s stock, valued at $8,172,299.52. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 1.00% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
- Get a free copy of the StockNews.com research report on Henry Schein (HSIC)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.